{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T19:45:05Z","timestamp":1770493505786,"version":"3.49.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,5]],"date-time":"2023-04-05T00:00:00Z","timestamp":1680652800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI105185"],"award-info":[{"award-number":["R01AI105185"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI163202"],"award-info":[{"award-number":["R01AI163202"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Resistance Updates"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.drup.2023.100959","type":"journal-article","created":{"date-parts":[[2023,4,5]],"date-time":"2023-04-05T23:13:41Z","timestamp":1680736421000},"page":"100959","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Pyrazinamide-resistant Tuberculosis Obscured From Common Targeted Molecular Diagnostics"],"prefix":"10.1016","volume":"68","author":[{"given":"Samuel J.","family":"Modlin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikael","family":"Mansj\u00f6","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jim","family":"Werngren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chidera M.","family":"Ejike","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sven E.","family":"Hoffner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3648-9384","authenticated-orcid":false,"given":"Faramarz","family":"Valafar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.drup.2023.100959_bib1","doi-asserted-by":"crossref","DOI":"10.1128\/Spectrum.00019-21","article-title":"Intragenic distribution of IS 6110 in clinical Mycobacterium tuberculosis strains: bioinformatic evidence for gene disruption leading to underdiagnosed antibiotic resistance","volume":"9","author":"Antoine","year":"2021","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.drup.2023.100959_bib2","doi-asserted-by":"crossref","first-page":"4928","DOI":"10.1128\/AAC.02394-14","article-title":"Association between pncA gene mutations, pyrazinamidase activity, and pyrazinamide susceptibility testing in Mycobacterium tuberculosis","volume":"58","author":"Aono","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drup.2023.100959_bib3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0177167","article-title":"Performance of TaqMan array card to detect TB drug resistance on direct specimens","volume":"12","author":"Banu","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.drup.2023.100959_bib4","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.00632-20","article-title":"Application of targeted next-generation sequencing assay on a portable sequencing platform for culture-free detection of drug-resistant tuberculosis from clinical samples","volume":"58","author":"Cabibbe","year":"2020","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.drup.2023.100959_bib5","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2147\/IDR.S230774","article-title":"Detection of novel gene mutations associated with pyrazinamide resistance in multidrug-resistant Mycobacterium tuberculosis clinical isolates in Southern China","volume":"13","author":"Hameed","year":"2020","journal-title":"Infect. Drug Resist."},{"key":"10.1016\/j.drup.2023.100959_bib6","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02338-2020","article-title":"Deep amplicon sequencing for culture-free prediction of susceptibility or resistance to 13 anti-tuberculous drugs","volume":"57","author":"Jouet","year":"2021","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.drup.2023.100959_bib7","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1021\/acs.jcim.8b00525","article-title":"Insights into the mechanisms of the pyrazinamide resistance of three pyrazinamidase mutants N11K, P69T, and D126N","volume":"59","author":"Junaid","year":"2019","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.drup.2023.100959_bib8","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1128\/AAC.00110-08","article-title":"Pyrazinamide resistance and pncA gene mutations in Mycobacterium tuberculosis","volume":"52","author":"Jur\u00e9en","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drup.2023.100959_bib9","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3390\/scipharm86020015","article-title":"Novel mutations in pncA gene of pyrazinamide resistant clinical isolates of Mycobacterium tuberculosis","volume":"86","author":"Kahbazi","year":"2018","journal-title":"Sci. Pharm."},{"key":"10.1016\/j.drup.2023.100959_bib10","doi-asserted-by":"crossref","first-page":"7154","DOI":"10.1002\/jcb.27989","article-title":"Pyrazinamide resistance and mutations L19R, R140H, and E144K in Pyrazinamidase of Mycobacterium tuberculosis","volume":"120","author":"Khan","year":"2019","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.drup.2023.100959_bib11","doi-asserted-by":"crossref","DOI":"10.1128\/MMBR.00070-19","article-title":"The bewildering antitubercular action of pyrazinamide","volume":"84","author":"Lamont","year":"2020","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"10.1016\/j.drup.2023.100959_bib12","doi-asserted-by":"crossref","first-page":"3252","DOI":"10.3389\/fmicb.2020.594171","article-title":"Characterization of pncA mutations and prediction of PZA resistance in Mycobacterium tuberculosis clinical isolates from Chongqing, China","volume":"11","author":"Li","year":"2021","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.drup.2023.100959_bib13","article-title":"Phenotypic and genotypic characterization of pyrazinamide resistance among 291 multidrug-resistant and extensive drug-resistant","author":"Liu","year":"2023","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.drup.2023.100959_bib14","doi-asserted-by":"crossref","first-page":"156","DOI":"10.4103\/ijmy.ijmy_23_17","article-title":"Characterization of pyrazinamide resistance in consecutive multidrug-resistant mycobacterium tuberculosis isolates in sweden between 2003 and 2015","volume":"6","author":"Mansjo","year":"2017","journal-title":"Int. J. Mycobacteriol."},{"key":"10.1016\/j.drup.2023.100959_bib15","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01916-20","article-title":"Atypical genetic basis of pyrazinamide resistance in monoresistant Mycobacterium tuberculosis","volume":"65","author":"Modlin","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drup.2023.100959_bib16","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.04077-2020","article-title":"Targeted next-generation sequencing: a Swiss army knife for mycobacterial diagnostics","volume":"57","author":"Mohamed","year":"2021","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.drup.2023.100959_bib17","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1186\/s12879-022-07329-y","article-title":"Evaluating the clinical impact of routine whole genome sequencing in tuberculosis treatment decisions and the issue of isoniazid mono-resistance","volume":"22","author":"Park","year":"2022","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.drup.2023.100959_bib18","doi-asserted-by":"crossref","first-page":"5267","DOI":"10.1128\/AAC.00204-15","article-title":"Systematic review of mutations in pyrazinamidase associated with pyrazinamide resistance in mycobacterium tuberculosis clinical isolates","volume":"59","author":"Ramirez-Busby","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drup.2023.100959_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0232343","article-title":"Detection of drug resistant Mycobacterium tuberculosis by high-throughput sequencing of DNA isolated from acid fast bacilli smears","volume":"15","author":"Rowneki","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.drup.2023.100959_bib20","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-017-2594-3","article-title":"Pyrazinamide resistance-conferring mutations in pncA and the transmission of multidrug resistant TB in Georgia","volume":"17","author":"Sengstake","year":"2017","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.drup.2023.100959_bib21","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.tube.2013.03.005","article-title":"PncA gene expression and prediction factors on pyrazinamide resistance in Mycobacterium tuberculosis","volume":"93","author":"Sheen","year":"2013","journal-title":"Tuberculosis"},{"key":"10.1016\/j.drup.2023.100959_bib22","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.00145-19","article-title":"Direct detection of pyrazinamide resistance in Mycobacterium tuberculosis by Use of pncA PCR sequencing","volume":"57","author":"Tam","year":"2019","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.drup.2023.100959_bib23","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1128\/JCM.01903-13","article-title":"Role of pncA and rpsA gene sequencing in detection of pyrazinamide resistance in mycobacterium tuberculosis isolates from southern China","volume":"52","author":"Tan","year":"2014","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.drup.2023.100959_bib24","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02091-20","article-title":"Systematic review of mutations associated with isoniazid resistance points to continuing evolution and subsequent evasion of molecular detection, and potential for emergence of multidrug resistance in clinical strains of mycobacterium tuberculosis","volume":"vol. 65","author":"Valafar","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drup.2023.100959_bib25","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1128\/JCM.02532-16","article-title":"Non-pncA gene-mutated but pyrazinamide-resistant Mycobacterium tuberculosis: Why is that?","volume":"55","author":"Werngren","year":"2017","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.drup.2023.100959_bib26","article-title":"Detection of Mycobacterium tuberculosis pncA mutations by the NIPRO Genoscholar \u2122 \u22c5PZA-TB II as compared to conventional sequencing","author":"Willby","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drup.2023.100959_bib27","unstructured":"World Health Organization, 2021. WHO Consolidated Guidelines on Tuberculosis Module 3: Rapid Diagnostics for Tuberculosis Detection. World Health Organization vol. Module 3. \u3008https:\/\/www.who.int\/publications\/i\/item\/9789240029415\u3009."},{"key":"10.1016\/j.drup.2023.100959_bib28","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-017-00721-2","article-title":"A comprehensive characterization of PncA polymorphisms that confer resistance to pyrazinamide","volume":"8","author":"Yadon","year":"2017","journal-title":"Nat. Commun."}],"container-title":["Drug Resistance Updates"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1368764623000420?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1368764623000420?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T04:59:55Z","timestamp":1761281995000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1368764623000420"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":28,"alternative-id":["S1368764623000420"],"URL":"https:\/\/doi.org\/10.1016\/j.drup.2023.100959","relation":{},"ISSN":["1368-7646"],"issn-type":[{"value":"1368-7646","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pyrazinamide-resistant Tuberculosis Obscured From Common Targeted Molecular Diagnostics","name":"articletitle","label":"Article Title"},{"value":"Drug Resistance Updates","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drup.2023.100959","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100959"}}